Administration of Bifidobacterium to infants with atopic dermatitis: Changes in fecal microflora and clinical symptoms

Journal of Applied Research

Volumn 5, Issue 2, 2005, Pages 387-396

  Taniuchi, Shoichiro ^a   Hattori, Kazuhiro ^a   Yamamoto, Akemi ^a   Sasai, Misa ^a   Hatano, Yasuko ^a   Kojima, Takatsugu ^a   Kobayashi, Yohnosuke ^a   Iwamoto, Hiroshi ^b   Yaeshima, Tomoko ^b  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

^b MORINAGA MILK INDUSTRY CO LTD   (Japan)

Author keywords

Atopic dermatitis; Bifidobacterium; Probiotics

Indexed keywords

BIFIDOBACTERIUM BREVE M 16V EXTRACT; CASEIN; NATURAL PRODUCT; PROBIOTIC AGENT; RAFFINOSE; UNCLASSIFIED DRUG;

AEROBIC BACTERIUM; ARTICLE; ARTIFICIAL MILK; ATOPIC DERMATITIS; BACTERIAL STRAIN; BACTERIUM CULTURE; BIFIDOBACTERIUM; BIFIDOBACTERIUM BREVE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FECES MICROFLORA; FEMALE; HUMAN; INFANT; MALE; MILK ALLERGY; PRESCHOOL CHILD; SCORING SYSTEM; SYMPTOM; TREATMENT OUTCOME;

EID: 21844444078     PISSN: 1537064X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Björkstén B, Naaber P, Sepp E, et al. The intestinal microflora in allergic Estonian and Swedish 2-year-old children. Clin Exp Allergy. 1999;29:342-346.
2. Wickens K, Pearce N, Crane J, et al. Antibiotic use in early childhood and the development of asthma. Clin Exp Allergy. 1999;29:766-771.
3. Kalliomäki M, Salminen S, Arvilommi H, et al. Probiotics in primary prevention of atopic disease: A randomized placebo-controlled trial. Lancet. 2001;357:1076-1079.
4. Hattori K, Sasai M, Yamamoto A, et al. Intestinal flora of infants with cow milk hypersensitivity fed on casein-hydrolyzed formula supplemented raffinose [in Japanese]. Arerugi. 2000;49:1146-1155.
5. Hanifin JM, Rajaka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol. 1980;92(suppl):44-47.
6. Yaeshima T, Takahashi S, Matsumoto N, et al. Effect of yogurt containing Bifidobacterium longum BB536 on the intestinal environment, fecal characteristics and defecation frequency: A comparison with standard yogurt. Bioscience Microflora. 1997;16:73-77.
7. Kimata H, Igarashi M. Topical cromolyn (disodium cromoglycate) solution in the treatment of young children with atopic dermatitis. Clin Exp Allergy. 1990;20:281-283.
8. Fukushima Y, Li ST, Hara H, et al. Effect of follow-up formula containing bifidobacteria (NAN BF) on fecal flora and fecal metabolites in healthy children. Bioscience Microflora. 1997;16:65-72.
9. Cleveland MG, Gorham JD, Murphy TL, et al. Lipoteichoic acid preparations of gram-positive bacteria induce interleukin-12 through a CD14-dependent pathway. Infec Immun. 1996;64:1906-1912.
10. Isolauri E, Majamaa H, Arvola T, et al. Lactobacillus casein strain GG reverses increased intestinal permeability induced by cow milk in suckling rats. Gastroenterology. 1993;105:1643-1645.
11. Kirjavainen PV, Salminen S, Isolauri E. Probiotic bacteria in the management of atopic disease: underscoring the importance of viability. J Pediatr Gastroenterol Nutr. 2003;36:223-227.